- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe - Abstract
November 16, 2011
Consolidating risk estimates for radiation-induced complications in individual patient: Late rectal toxicity - Abstract
November 16, 2011
Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage? - Abstract
November 16, 2011
Effects of commercially available soy products on PSA in androgen-deprivation-naïve and castration-resistant prostate cancer - Abstract
November 16, 2011
Prostate brachytherapy and second primary cancer risk: A competitive risk analysis - Abstract
November 16, 2011
Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis - Abstract
November 16, 2011
Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer - Abstract
November 16, 2011
Couples surviving prostate cancer: Challenges in their lives and relationships - Abstract
November 15, 2011
Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen - Abstract
November 15, 2011
A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer - Abstract
November 15, 2011
Day-to-day reproducibility of prostate intrafraction motion assessed by multiple kV and MV imaging of implanted markers during treatment - Abstract
November 15, 2011
Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatment - Abstract
November 15, 2011
Prostate cancer detection on dynamic contrast-enhanced MRI: Computer-aided diagnosis versus single perfusion parameter maps - Abstract
November 15, 2011
Cancer screening: Curative or harmful? : An ethical dilemma facing the physician - Abstract
November 14, 2011
Intravenous therapies for castration-resistant prostate cancer: Toxicities and adverse events - Abstract
November 14, 2011